ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its ...
The past month has been a wild ride in the United States. The White House is engaged in fights over trade and taxes; the Federal Reserve is at ...
European markets are heading for a higher open, with investor focus on the German government as it votes on historic debt ...
And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...
Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...
UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00.Discover the ...
Stock futures are little changed Wednesday night after the major averages rebounded on hopes for concessions on President Donald Trump's tariffs. Futures tied to the Dow Jones Industrial Average ...
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird BioscienceFinancing ...
Portuguese state-owned bank Caixa Geral de Depositos SA is analyzing the possible acquisition of Novo Banco SA, a smaller lender that’s preparing an initial public offering. “We are analyzing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results